A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1
| Status: | Archived |
|---|---|
| Conditions: | Infectious Disease, Hepatitis |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | October 2010 |
A Phase 1b Study to Assess the Safety, Antiviral Efficacy and Pharmacokinetics of PPI-461 in Patients With HCV Genotype-1 Infection
The purpose of the study is to assess the safety, tolerability, antiviral effects, and
pharmacokinetics of PPI-461 in patients with chronic hepatitis C virus genotype 1 infection.
We found this trial at
1
site
Click here to add this to my saved trials
